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ABSTRACT: The objective of this study is to investigate the antimicrobial activity of novel 
Schiff base metal complexes. The resistance of micro-organisms to classical antimicrobial 
compounds poses a challenge to effective management and treatment of some diseases. In line 
with this, copper (II), nickel (II) and cobalt (II) complexes of the Schiff base ligand (E)-N’-(2-
hydroxy-5-nitrobenzylidene) isonicotinohydrazide) were synthesized and characterized based on 
elemental analysis, conductivity measurements, infrared and electronic absorption spectroscopy. 
The results suggest a 1:2 [M:L] stoichiometry for the copper and cobalt complexes and a 1:1 
[M:L] ratio for the nickel complex. The electronic absorption spectral data support octahedral 
geometry for cobalt(II) and copper(II) complexes and square planar for nickel (II). In-vitro 
antimicrobial properties of the compounds evaluated against five pathogenic bacteria using the 
agar-well diffusion method revealed that the activity was in the order Ni>Co>Cu. These 
compounds can be used as substrates for development of new antimicrobial agents. © JASEM 
http://dx.doi.org/10.4314/jasem.v21i1.13 
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Hydrazones are Schiff bases containing two adjacent 
nitrogen atoms in which both nitrogen atoms are 
nucleophilic and the azomethine carbon possesses 
both electrophilic and nucleophilic character. These 
compounds have received much attention as a result 
of their interesting properties and important 
applications. They are used widely in organic 
synthesis (Brehme et al., 2007), analytical chemistry 
(Tezcan et al., 2008) and in medical biotechnology 
(Sigel et al., 2004). Hydrazones have been reported 
to demonstrate broad spectrum of biological activities 
including antimicrobial, antituberculosis, anti-
inflammatory, anticancer, anticonvulsant and 
analgesic activities. (Wang et al., 2014; Kaushik et 
al., 2010; Jordão et al., 2011)  
 
Schiff bases of aroyl, acyl and heteroacyl hydrazones 
are more versatile and flexible as a result of the 
carbonyl group present which introduces an 
additional donor site in the molecule. These 
compounds exhibit high and selective anti-
proliferative activities (Ommis et al., 2016). For 
example, salicyladehyde benzoylhydrazone has been 
shown to be a potent inhibitor of DNA synthesis and 
cell growth in some cultured human and rodent cells. 
(Johnson et al., 1982). Furthermore, 2-
hydroxynapthaldehyde-trimethoxybenzoylhydrazone 
is an efficient chelator of intracellular trace metals 
with high anticancer properties. Hydrazones of 
isonicotinic hydrazide are used in treatment of iron 
overload and as pharmacophore in design of anti-
convulsant drugs (Kim et al., 2010).  
 
There is a growing interest in the coordination 
chemistry of aroylhydrazones based on reports of 
formation of stable bioactive metal chelates with 
various transition metal ions (Ogunniran et al., 2015; 
Rakesh et al., 2009). 
 
In particular, Schiff bases of isonicotinic hydrazide 
(INH) a first line anti-tuberculosis drug, the 
isonicotincoyl hydrazones have been shown to form 
bioactive metal chelates with many bivalent ions 
(Chohan et al., 2006; Sharma et al., 2010). 
 
In this paper, we report the synthesis, spectroscopic 
and antimicrobial properties of the cobalt, nickel and 
copper complexes of a Schiff base, (5-nitro-2-
hydroxybenzylidene) isonicotinoyl hydrazide derived 
from 5-nitro-isonicotinic hydrazide and 2-hydroxy-5-
nitrobenzyaldehyde. 
 
MATERIALS AND METHODS 
 Chemicals used were of highest purity available and 
purchased from Sigma Aldrich Chemicals Ltd, 
Germany.  
 
 The solvents were of analytical grade and used 
without further purification. The complexes were 
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synthesized using the method reported by Fernandez 
et al., (2010). 
 
Physical measurements and analyses: Melting points 
(
o
C) were determined on a Stuart SMP3 melting point 
apparatus and are uncorrected. Elemental analyses 
were performed with a Perkin -Elmer 2400 CHNS/O 
analyzer. Solution electronic absorption spectra were 
recorded in DMF on a Cecil Super Aquarius 9000 
series UV-vis spectrophotometer. The infrared (IR) 
spectra were recorded on an FTS 7000 series Digilab 
Win-IR Pro spectrometer equipped with a diamond 
ATR accessory in the range 4000 to 400 cm
-1
. The 
Raman spectroscopic analysis was carried out using 
MultiRam FR-Raman Spectrometer with Nd-YAG 
laser which lasers in the near infrared at 1064 nm 
equipped for the collection of fluorescence-free 




C NMR spectra were 
recorded in DMSO-d6 on a Varian Mercury 300 MHz 
NMR spectrometer and the chemical shifts quoted 
relative to the solvent peaks. Conductivity 
measurements were obtained in DMF solutions using 
a DDS-307 conductivity meter.  
 
Synthesis of (E)-N’-(2-hydroxy-5- 
nitrobenzylidene)isonicotinoylhydrazide)  (DF):  2-
hydroxy-5-nitrobenzyaldehyde (300 mg, 1.8 mmol.) 
was added to a homogenous solution of isonicotinic 
acid hydrazide (246 mg, 1.8 mmol.) in hot DMSO 
(20 mL) and the mixture refluxed for 8 h.  The 
mixture was allowed to cool to room temperature, the 
solvent removed under reduced pressure and the 
yellow solid obtained was recrystallized from DMSO 
and dried in a desiccator. 
 
 Yield:  89% (0.49 g). m.p.: 310 
o
C; IR (ATR, cm
-1
):  
3305, 3069, 1664, 1608, 1582, 1550, 1480, 1439, 
1373, 1338, 1296, 961, 839, 750, 685. Raman 
(Solid/1064nm): 3074, 1617, 1600,  1585, 1518, 





(300 MHz, DMSO-d6) δH: 7.13 (d, J 9.3Hz, 
1H), 7.86 (d, J 6.3Hz, 2H), 8.20 (d, J 9.0Hz, 1H), 
8.61 (d, J 3.0Hz, 1H), 8.76 (s, 1H), 8.81 (d, J 4.8Hz, 
2H), 12.20 (s, 1H ); 12.42 (s, 1H ); 
13
C NMR (75 
MHz, DMSO-d6) δC: 117.68, 120.59, 122.07, 123.85, 
127.44, 140.40, 145.41, 150.94, 162.17, 163.22 
Anal. Calcd for C13H10N4O4: C: 54.24, H: 3.80, N: 
19.37. Found: C: 54.55, H: 3.52, N: 19.57. 
   
General synthesis of metal complexes: The metal 
chloride (1.1 mmol) in 1:2 ethanol/water mixture (30 
mL) was added to a degassed mixture of isonicotinic 
acid hydrazide (274 mg, 2 mmol) and 2-hydroxy-5-
nitrobenzyaldehyde (334 mg, 2 mmol) in ethanol (20 
mL), was refluxed under nitrogen for 6 h.  The 
mixture was allowed to cool to room temperature and 
the solid obtained was filtered, washed with water, 










): 3066, 1602, 1496, 1365, 1321, 1242, 1191, 
1129, 1100, 946, 896, 795, 731, 692, 597, 518, 467, 
446. Raman (Solid/1064nm): 3051, 1616, 1571, 
1552, 1419, 1378, 1326, 1217, 1194, 1156, 1052, 
923, 843, 799, 654. 
Anal. calcd. for C26H20Cl2CuN8O8: C, 44.17, H, 2.85, 
N, 15.85, Cu, 8.99. Found: C, 44.16, H, 2.40, N, 
15.23, Cu, 9.91. 
 
(E)-N’-(2-hydroxy-5nitrobenzylidene) 
isonicotinohydrazide)nickel(II) chloride hydrate 





):3358, 3050, 1595, 1541, 1418, 1384, 1269, 
1086, 951, 907, 834, 754, 720, 631, 587, 517. Raman 
(Solid/1064nm): 3069, 1611, 1552, 1508, 1374, 
1312, 1194, 1049, 842, 665. 
Anal. calcd. for C13H17ClN4NiO8: C, 34.59, H, 3.80, 
N, 12.41, Ni, 13.00. Found: C, 34.86, H, 3.40, N, 











): 3294, 3067, 1595, 1545, 1492, 1458, 1437, 
1296, 1242, 1099, 961, 922, 832, 750, 686, 579, 511, 
456. Raman (Solid/1064nm):  1609, 1574, 1550, 
1520, 1385, 1315, 1217, 1055, 1035, 844, 810. 
Anal. calcd. for C26H24CoN8O11: C, 45.69, H, 3.54, 
N, 16.40, Co, 8.62. Found: C, 45.70, H, 3.12, N, 
16.00, Co, 8.72. 
 
Antibacterial studies: The in-vitro antibacterial 
activity of the ligand and metal complexes was 
evaluated using the agar-well diffusion method 
Valgas et al., (2007).  The compounds were screened 
against Staphylococcus aureus, Entercoccus feacalis, 
Escherichia coli, Shigella and Salmonella typhi using 
a solution containing 2.5 mg of each compound 
dissolved in 1 mL N,N-dimethylformamide (DMF). 
 
A double layered aseptically prepared Muller Hinton 
agar plate was flooded with standardized (0.5 
McFarland) test microorganism and allowed to stand 
for two minutes. A sterilized cork borer (1 mm) was 
used to make five radial wells, which were filled with 
the test compounds using a micropipette and then 
incubated at 37
 o
C for 24 h. During this period, the 
test compound diffused and the growth of the 
inoculated microorganism was affected. The diameter 
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of the zone of inhibition surrounding each well was 
measured and recorded. In order to clarify any 
participating role of the solvent in the biological 
screening, control test was included using the solvent 
alone to fill the control well. 
 
RESULTS AND DISCUSSION 
Condensation of isonicotinic acid hydrazide with 2-
hydroxy-5-nitrobenzyaldehyde readily gave rise to 
the Schiff base (E)-N’-(2-hydroxy-5-













Fig 1: (E)-N’-(2-hydroxy-5-nitrobenzylidene)  
isonicotinoylhydrazide)   
 
The formation of the Schiff base was confirmed on 
the basis of a sharp melting point, characteristic band 
at 1608 cm
-1
 in the FT-IR spectrum and resonance 
signals at 8.76 ppm in the 
1
H NMR for the HC=N- 
group (Figure 2). The formation was further 
confirmed by the presence of a signal at 145 ppm in 
the 
13





HNMR of Schiff base DF 
 
The reaction of the Schiff base DF with chloride salts 
of Cu(II), Ni(II) and Co(II) afforded the metal 
complexes in moderate yields. All the complexes 
were stable in air, insoluble in common organic 
solvents such as ethanol, methanol, acetone, diethyl 
ether, chloroform, but soluble in DMF and DMSO.  
 
The analytical data of the compounds reported in 
Table 1 are in good agreement with the calculated 
values and suggest a 1:2 metal: ligand ratio for the 
complexes. The low molar conductivity values of 
DF1 and DF3 indicate that the complexes are 
essentially non-electrolytes, however, the value for 
DF2 suggest it is a 1:1 electrolyte with formula  
[Ni(DF).nH2O]Cl.nH2O. (Melha, 2008). 
 
Table 1  Physical and analytical data of the ligand and its complexes 
  Yield %  mp oC Λ Scm-1 Elemental analysis Calculated (Found) 
 %C                    %H                  % N 
DF  89 Yellow 310 - 54.24(54.55)      3.8 (3.52)           19.37(19.57) 
DF1 [Cu(DF)2Cl2] 66 Green >349.0 3.75 44.17 (44.16)      2.85(2.40)          15.85(15.23) 
DF2 [Ni(DF).3H2O]Cl.H2O 56 Brown >349.0 48.20 34.59 (34.86)       3.80 (3.40)        12.41 (12.38) 
DF3 [Co(DF)2].3H2O 65 Dark red >349.0 2.44 45.69 (45.70)       3.54 (3.12)        16.40 (16.00) 
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In order to determine the binding mode of the Schiff 
base to the metal in the complexes, the IR spectrum 
of the ligand was compared to the spectra of the 
metal complexes. The diagnostic IR spectral bands 
for the ligand (DF) and its metal complexes (DF1 – 
DF3) presented in Table 2. 
 
 Table 2: Diagnostic infrared data of DF and its metal complexes 
Complex 
code 
v(H2O) vN-H vC=O vN-N vC=N νOH vC-O v(M-O) v(M-N) 
DF  3305 1664 1554 1608 1373 1296   
DF1 - 3066 - 1496 1602 1365 1321 518 446 
DF2 3358 3050 1642 1541 1595 1384 1269 587 517 
DF3 - 3067 - 1545 1595 1296 1246 511 456 
 
All metal complexes exhibit a band in the region 
1598 – 1605 cm
-1
, attributed to the imine group in the 
Schiff base. The observed decrease in frequency 
compared to the corresponding band in the free 
ligand indicates the use of the imine nitrogen in 
metal-ligand coordination. 
 
The absence of the band characteristic of carbonyl 
amide at 1664 cm
-1
 in DF1 and DF3 suggest that 
amido-imido tautomerism took place before 
complexation. This observation is corroborated by 
decrease in the NH bending vibrations of the metal 
complexes compared to the ligands. In DF2, the 
carbonyl amide band is shifted to lower frequency 
indicating tautomerism does not occur in the nickel 
complex and the carbonyl is used in coordination to 
the metal.  
 
The deformation vibration of the phenolic OH group 
which appeared at 1339 cm
-1
 in the spectrum of the 
ligand was shifted to higher or lower frequencies in 
the metal complexes, thus indicating its involvement 
in coordination.  
 





characteristic of the metal-nitrogen and 
metal – oxygen stretching vibration supports the 
involvement of nitrogen and oxygen atoms in 
complexation. 
 
Of interest is the broad band observed in the region 
3245 cm
-1 
for DF2 indicating the presence of 
coordinated water molecules in the compound. The 
comparison of bands for outer sphere coordinated 
water is somewhat difficult. This could be attributed 
to its loss while drying the complexes in the 
desiccator prior to the analysis.  
 
The electronic spectra of the Schiff base and the 
metal complexes in DMF were recorded over the 
wavelength 250 - 700 nm at room temperature and 
the spectral data presented in Table 3
. 
Table 3:  Electronic absorption data the Schiff Base and its metal complexes 
Compound λmax  (cm
-1) Assignment Geometry 
DF 34722, 25773 π−  π∗, n − π∗  
DF1 35714, 27624, 20366 π−  π∗, n − π∗,  d -d Octahedral 
DF2 35211, 29585, 22867 π−  π∗, n − π∗,  d -d Square Planar 
DF3 29767, 16482, 14352 π−  π∗, d-d,  d -d Octahedral 
 
The spectrum of the ligand   consists of two bands in 
the UV region at 34722 and 25773 cm
-1 
arising from 
the π− π* and n-π* transitions respectively. In 
addition to the π−π∗ and n-π* transitions observed in 
the Ni(II) and Cu(II) complexes, a band was observed 
at 20366 cm
-1 
in the Cu(II) complex.  This was 
assigned to an Eg      T2g transition, thus suggesting an 
octahedral geometry for copper in the complex. The 
band at 22867 cm
-1 
in Ni(II) complex corresponds to 
a A1g     A2g transition in a square planar environment 
(Raman et al., 2003). The absorption bands observed 
at 16482 and 14352 cm
-1 
in the Co(II) complex is 
assigned to the 
4




T1g(F)   
4
T1g (P) transitions in an octahedral field. 
(Raman et al., 2010). The third transition expected 
corresponding to 
4
T1g(F)      
4
T2g (F)  was not 
observed due to limitation of the spectrophotometer 
used.  
 
The Schiff base and its metal complexes were 
screened for antibacterial activity against S. aureus, 
E. feacalis, E. coli, Shigella and S. thyphi in DMF 
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   Code: + = active; ++ = moderately active; +++ = highly active; 0 = inactive 
 
The in-vitro biological activity of a compound 
depends on its structure, ability to survive in the 
condition used (temperature, solvent etc.) and 
morphology of the cell wall. The morphology of the 
cell wall is a key factor that influences the activity of 
antibacterial agents. The cell wall of the bacterial is 
composed of peptidoglycan which is thicker in the 
gram-negative bacteria and this usually poses a 
barrier to the degree of diffusion of antibacterial 
agent into the enzyme (Mims et al., 2004). 
 
The antibacterial study revealed that all the 
compounds have the capacity to inhibit metabolic 
growth of the bacterial species to different extents. 
The Schiff base was inactive against the species 
studied expect for Shigella and Salmonella bacterial 
strains. Previous reports indicate that the presence of 
a metal ion can enhance or suppress the biological 
activity of a biologically active compound. The 
higher activity of the metal complex may be due to 
the effect of metal ions on the normal cell membrane. 
The crucial action of a toxicant is the denaturation of 
one or more proteins of the cell, which impairs 
normal cellular processes. Delocalization of lipid 
layer of the bacterial cell membrane which seems to 
be responsible for their enhanced potent antibacterial 
activity
 
(Rehder, 2003).  
In this study, the Ni(II) complex was found to be 
more active than the ligand DF, Cu(II) and Co(II) 
complexes. This could be attributed to the structure 
of the nickel complex which allowed for easier 
chelate formation with the bacterial strains tested. 
The trend in activity of the compounds was found to 
be in the order Ni>Co>Cu. The compounds showed 
no discrimination for the type of bacterial strains, 
hence are suitable for development on broad 
spectrum antibacterial agents. Further work on the 
cytotoxicity of the compounds is being carried out. 
 
Conclusion: The synthesis and bacterial study of an 
aroylhydrazone derived from isonicotinic hydrazide 
and 2-hydroxy-5-nitrobenzaldehyde and the Cu(II), 
Ni(II) and Co(II) complexes is described. 
Comparative in-vitro antibacterial study revealed that 
the metal complexes showed enhanced inhibitory 
activity compared to the ligand with the nickel 
complex exhibiting highest activity. The results 
indicate the Schiff base metal complexes can be 
utilized in the development of new antibacterial 
agents making them suitable for further exploration. 
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